0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
INFLUENTIAL PUBLICATIONS   |    
Bibliography: Bipolar Disorder
FOCUS 2011;9:466-467. doi:10.1176/appi.focus.9.4.466
Angst J, Azorin J-M, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH: Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode.  Arch Gen Psychiatry 2011; 68:791–799
 
Fiedorowicz JG, Endicott J, Leon AC, Solomon DA, Keller MB, Coryell WH: Subthresold hypomanic symptoms in progression from unipolar major depression to bipolar disorder.  Am J Psychiatry 2011; 168:40–48
 
Gruber J, Miklowitz DJ, Harvey AG, Frank E, Kupfer D, Thase ME, Sachs GS, Ketter TA: Sleep matters: sleep functioning and course of illness in bipolar disorder.  J Affect Disord 2011; 134:416–420
 
Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE, Kieseppä T, Altshuler LL, Fornito A, Malhi GS, McIntosh AM, Yurgelun-Todd DA, Labar KS, Sharma V, MacQueen GM, Murray RM, McDonald C: Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data.  Biol Psychiatry 2011; 69:326–335
 
Sachs GS, Dupuy JM, Wittmann CW: The pharmacologic treatment of bipolar disorder.  J Clin Psychiatry 2011; 72:704–715
 
Sidor MM, MacQueen GM: Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.  J Clin Psychiatry 2011; 72:156–167
 
Vieta E, Blasco-Colmenares E, Figueira ML, Langosch JM, Moreno-Manzanaro M, Medina E, WAVE-bd Study Group: Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd study).  BMC Psychiatry 2011; 11:58
 
Amsterdam JD, Shults J: Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.  Am J Psychiatry 2010; 167;792–800
 
BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E: Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.  Lancet 2010; 375:385–395
 
Ellison-Wright I, Bullmore E: Anatomy of bipolar disorder and schizophrenia: a meta-analysis.  Schizophr Res 2010; 117:1–12
 
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression.  World J Biol Psychiatry 2010; 11:81–109
 
Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS, Lieberman J, Hamilton SP, Sullivan P, Sklar P, Purcell S, Smoller JW: Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.  Am J Psychiatry 2010; 167:1254–1263
 
Parikh SV, LeBlanc SR, Ovanessian MM: Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).  Can J Psychiatry 2010; 55:136–143
 
Perlis RH, Ostacher MJ, Goldberg JF, Miklowitz DJ, Friedman E, Calabrese J, Thase ME, Sachs GS: Transition to mania during treatment of bipolar depression.  Neuropsychopharmacology 2010; 35:2545–2552
 
Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, Zarate CA: The neurobiology of the switch process in bipolar disorder: a review.  J Clin Psychiatry 2010; 71:1488–1501
 
Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M, EMBOLDEN I TRIAL 001 Investigators: A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).  J Clin Psychiatry 2010; 71:150–162
 
Zimmerman M, Ruggero CJ, Chelminski I, Young D: Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder.  J Clin Psychiatry 2010; 71:26–31
 
Frye MA, Helleman G, Mcelroy SL, Altshuler LL, Black DO, Keck PE, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T: Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.  Am J Psychiatry 2009; 166:164–172
 
Geddes JR, Calabrese JR, Goodwin GM: Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.  Br J Psychiatry 2009; 194:4–9
 
Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sachs GS: Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.  Am J Psychiatry 2009; 166:173–181
 
Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.  J Clin Psychiatry 2009; 70:1078–1090
 
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.  World J Biol Psychiatry 2009; 10:85–116
 
International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.  Nature 2009; 460:748–752
 
Martinowich K, Schloesser RJ, Manji HK: Bipolar disorder: from genes to behavior pathways.  J Clin Invest 2009;119:726–736
 
Miklowitz DJ, Scott J: Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions.  Bipolar Disord 2009;11(Suppl 2):110–122
 
Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, Beaulieu S, Yatham LN, Berk M: The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.  Bipolar Disord 2009; 11:559–595
 
Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M: The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.  Bipolar Disord 2009; 11:453–473
 
Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM Advisory Board: Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).  J Affect Disord 2009; 118:118–123
 
Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, Macqueen G, Mcintyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, Calabrese Jr, Berk M, Ha K, Kapczinski F: Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update.  Bipolar Disord 2009; 11:225–255
 
Zimmermann P, Bruckl T, Nocon A, Pfister H, Lieb R, Wittchen H-U, Holsboer F, Angst J: Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.  Arch Gen Psychiatry 2009; 66:1341–1352
 
Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, de Ridder D, Kupka RW, Nolen WA, Drexhage HA: A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.  Arch Gen Psychiatry 2008; 65:395–407
 
Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP: Interventions for helping people recognise early signs of recurrence in bipolar disorder.  Cochrane Database Syst Rev 2007; 1:CD004854
 
Sachs GS: Bipolar disorder clinical synthesis: where does the evidence lead?  Focus 2007; 5:3–13
 
References Container
+

References

Angst J, Azorin J-M, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH: Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode.  Arch Gen Psychiatry 2011; 68:791–799
 
Fiedorowicz JG, Endicott J, Leon AC, Solomon DA, Keller MB, Coryell WH: Subthresold hypomanic symptoms in progression from unipolar major depression to bipolar disorder.  Am J Psychiatry 2011; 168:40–48
 
Gruber J, Miklowitz DJ, Harvey AG, Frank E, Kupfer D, Thase ME, Sachs GS, Ketter TA: Sleep matters: sleep functioning and course of illness in bipolar disorder.  J Affect Disord 2011; 134:416–420
 
Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE, Kieseppä T, Altshuler LL, Fornito A, Malhi GS, McIntosh AM, Yurgelun-Todd DA, Labar KS, Sharma V, MacQueen GM, Murray RM, McDonald C: Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data.  Biol Psychiatry 2011; 69:326–335
 
Sachs GS, Dupuy JM, Wittmann CW: The pharmacologic treatment of bipolar disorder.  J Clin Psychiatry 2011; 72:704–715
 
Sidor MM, MacQueen GM: Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.  J Clin Psychiatry 2011; 72:156–167
 
Vieta E, Blasco-Colmenares E, Figueira ML, Langosch JM, Moreno-Manzanaro M, Medina E, WAVE-bd Study Group: Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd study).  BMC Psychiatry 2011; 11:58
 
Amsterdam JD, Shults J: Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.  Am J Psychiatry 2010; 167;792–800
 
BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E: Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.  Lancet 2010; 375:385–395
 
Ellison-Wright I, Bullmore E: Anatomy of bipolar disorder and schizophrenia: a meta-analysis.  Schizophr Res 2010; 117:1–12
 
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression.  World J Biol Psychiatry 2010; 11:81–109
 
Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS, Lieberman J, Hamilton SP, Sullivan P, Sklar P, Purcell S, Smoller JW: Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.  Am J Psychiatry 2010; 167:1254–1263
 
Parikh SV, LeBlanc SR, Ovanessian MM: Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).  Can J Psychiatry 2010; 55:136–143
 
Perlis RH, Ostacher MJ, Goldberg JF, Miklowitz DJ, Friedman E, Calabrese J, Thase ME, Sachs GS: Transition to mania during treatment of bipolar depression.  Neuropsychopharmacology 2010; 35:2545–2552
 
Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, Zarate CA: The neurobiology of the switch process in bipolar disorder: a review.  J Clin Psychiatry 2010; 71:1488–1501
 
Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M, EMBOLDEN I TRIAL 001 Investigators: A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).  J Clin Psychiatry 2010; 71:150–162
 
Zimmerman M, Ruggero CJ, Chelminski I, Young D: Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder.  J Clin Psychiatry 2010; 71:26–31
 
Frye MA, Helleman G, Mcelroy SL, Altshuler LL, Black DO, Keck PE, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T: Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.  Am J Psychiatry 2009; 166:164–172
 
Geddes JR, Calabrese JR, Goodwin GM: Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.  Br J Psychiatry 2009; 194:4–9
 
Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sachs GS: Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.  Am J Psychiatry 2009; 166:173–181
 
Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.  J Clin Psychiatry 2009; 70:1078–1090
 
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.  World J Biol Psychiatry 2009; 10:85–116
 
International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.  Nature 2009; 460:748–752
 
Martinowich K, Schloesser RJ, Manji HK: Bipolar disorder: from genes to behavior pathways.  J Clin Invest 2009;119:726–736
 
Miklowitz DJ, Scott J: Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions.  Bipolar Disord 2009;11(Suppl 2):110–122
 
Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, Beaulieu S, Yatham LN, Berk M: The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.  Bipolar Disord 2009; 11:559–595
 
Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M: The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.  Bipolar Disord 2009; 11:453–473
 
Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM Advisory Board: Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).  J Affect Disord 2009; 118:118–123
 
Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, Macqueen G, Mcintyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, Calabrese Jr, Berk M, Ha K, Kapczinski F: Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update.  Bipolar Disord 2009; 11:225–255
 
Zimmermann P, Bruckl T, Nocon A, Pfister H, Lieb R, Wittchen H-U, Holsboer F, Angst J: Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.  Arch Gen Psychiatry 2009; 66:1341–1352
 
Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, de Ridder D, Kupka RW, Nolen WA, Drexhage HA: A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.  Arch Gen Psychiatry 2008; 65:395–407
 
Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP: Interventions for helping people recognise early signs of recurrence in bipolar disorder.  Cochrane Database Syst Rev 2007; 1:CD004854
 
Sachs GS: Bipolar disorder clinical synthesis: where does the evidence lead?  Focus 2007; 5:3–13
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 1.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 2.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 2.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 5.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 5.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
APA Guidelines
PubMed Articles